Delivery Order SPE2DB20D3104-SPE2DB24FV8W0

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $2,833.59 fixed-price contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML pharmaceutical products. The order has a completion date of July 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous indefinite delivery contracts (IDCs) by the DLA and other federal agencies to supply a wide range of medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,760.82, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 16, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,200.38, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract is a firm-fixed price delivery order with a completion date of May 28, 2025. This contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $1,622.84 firm fixed price contract is for the provision of 4564754271 - NOVOLOG 100 UNIT/ML VIAL 10ML, with a completion date of May 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $1,944.90, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award, valued at $3,913.81, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,296.60, is a delivery order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML. The contract has a firm fixed price pricing type and an ultimate completion date of April 14, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation for this...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,944.90, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of February 4, 2025. This contract award is not associated with any set-aside designation, indicating open...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML medical supplies. The $2,595.98 firm fixed-price contract has a completion date of March 17, 2025. It is an individual delivery order issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award, valued at $1,640.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used for healthcare purposes. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 22, 2025. The contract does not have a set-aside designation,...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV8W0
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $1,509.60, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The award has a firm fixed price pricing type and an ultimate completion date of August 19, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities and veterans' hospitals. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, which serve as primary vehicles for providing a wide range of medical commodities to support federal healthcare needs. This contract award is not designated as a set-aside.

Generated 11/15/24, 9:28 AM